Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

Clinical trial NCT00183976 · TERMINATED

Trial details

NCT number: NCT00183976
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Burkitt Lymphoma Primary Effusion Lymphomas

Start date: 2005-04-01
Primary completion: 2005-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.